These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11473951)

  • 1. Changes in the biological:immunological ratio of basal and GnRH-releasable FSH during the follicular, pre-ovulatory and luteal phases of the human menstrual cycle.
    Zariñán T; Olivares A; Söderlund D; Méndez JP; Ulloa-Aguirre A
    Hum Reprod; 2001 Aug; 16(8):1611-8. PubMed ID: 11473951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle.
    Zambrano E; Olivares A; Mendez JP; Guerrero L; Díaz-Cueto L; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 1995 May; 80(5):1647-56. PubMed ID: 7745013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution and in vitro biological-to-immunological ratio in male puberty.
    Olivares A; Söderlund D; Castro-Fernández C; Zariñán T; Zambrano E; Méndez JP; Ulloa-Aguirre A
    Endocrine; 2004; 23(2-3):189-98. PubMed ID: 15146100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
    Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role.
    Dafopoulos K; Kotsovassilis CG; Milingos S; Kallitsaris A; Galazios G; Zintzaras E; Sotiros P; Messinis IE
    Hum Reprod; 2004 Sep; 19(9):1985-92. PubMed ID: 15229199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE; Schoenfeld DA; Martin KA; Crowley WF
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
    Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
    Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Messinis IE
    Hum Reprod; 2009 Apr; 24(4):976-81. PubMed ID: 19095668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM; Lunn SF; Morris KD; Deghenghi R
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase.
    Cagnacci A; Paoletti AM; Soldani R; Orrù M; Maschio E; Melis GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1095-9. PubMed ID: 7714075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.